![David N. Judelson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David N. Judelson
Career history of David N. Judelson
Former positions of David N. Judelson
Companies | Position | Start | End |
---|---|---|---|
Digital Compression Technology LP | Chairman | 31/12/1992 | 16/09/2018 |
Biopure Corp.
![]() Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA. | Director/Board Member | 31/12/1983 | - |
Founder | 16/11/2009 | - | |
Corporate Officer/Principal | 31/12/1983 | 16/11/2009 |
Training of David N. Judelson
New York University | Undergraduate Degree |
Statistics
International
United States | 4 |
Operational
Director/Board Member | 1 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Biopure Corp.
![]() Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA. | Health Technology |
Digital Compression Technology LP |
- Stock Market
- Insiders
- David N. Judelson
- Experience